Literature DB >> 15043107

Early osteolysis associated with trunion-liner impingement.

Mark Earll1, Thomas Fehring, William L Griffin, J Bohannon Mason, Thomas H McCoy.   

Abstract

Osteolysis is perhaps the biggest unsolved problem in joint arthroplasty. Many factors contribute to osteolysis, some of which cannot be controlled. It is imperative to minimize controllable factors contributing to osteolysis whenever possible. We report four cases of trunion impingement on an elevated rim liner, which may have contributed to early aggressive osteolysis. Although the use of an elevated liner may result in a lower incidence of postoperative instability, the trade-off in using such a device must be understood.

Entities:  

Mesh:

Year:  2004        PMID: 15043107     DOI: 10.1097/00003086-200401000-00024

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  The association between the sagittal femoral stem alignment and the resulting femoral head centre in total hip arthroplasty.

Authors:  Michael Müller; Dirk Crucius; Carsten Perka; Stephan Tohtz
Journal:  Int Orthop       Date:  2010-06-13       Impact factor: 3.075

2.  Do large femoral heads reduce the risks of impingement in total hip arthroplasty with optimal and non-optimal cup positioning?

Authors:  Gianluca Cinotti; Niccolò Lucioli; Andrea Malagoli; Carlo Calderoli; Ferdinando Cassese
Journal:  Int Orthop       Date:  2010-02-17       Impact factor: 3.075

Review 3.  Total hip arthroplasty instability in Italy.

Authors:  Francesco Falez; Matteo Papalia; Fabio Favetti; Gabriele Panegrossi; Filippo Casella; Gianluca Mazzotta
Journal:  Int Orthop       Date:  2016-12-20       Impact factor: 3.075

4.  Risk of impingement and third-body abrasion with 28-mm metal-on-metal bearings.

Authors:  Ian C Clarke; Jean-Yves Lazennec; Adrien Brusson; Christina Savisaar; John G Bowsher; Michelle Burgett; Thomas K Donaldson
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.